Epinephrine dosing interval and survival outcomes during pediatric in-hospital cardiac arrest

Derek B Hoyme1, Sonali S Patel2, Ricardo A Samson3

  • 1Stead Family Department of Pediatrics, University of Iowa Children's Hospital, Iowa City, IA, United States.

Resuscitation
|May 30, 2017
PubMed

Insights

Longer epinephrine dosing intervals during pediatric in-hospital cardiac arrest (IHCA) are linked to better survival rates. This finding challenges current guidelines recommending shorter intervals for improved outcomes in children.

Area of Science:

  • Pediatric critical care medicine
  • Cardiopulmonary resuscitation research
  • Clinical trial methodology

Background:

  • Current guidelines suggest epinephrine administration every 3-5 minutes during cardiopulmonary resuscitation.
  • Previous studies in adults with in-hospital cardiac arrest (IHCA) indicate that longer epinephrine dosing intervals correlate with improved survival to discharge.
  • The efficacy of extended epinephrine dosing intervals in pediatric IHCA remains to be fully elucidated.

Purpose of the Study:

  • To investigate the association between longer epinephrine dosing intervals and survival to hospital discharge in pediatric patients experiencing in-hospital cardiac arrest (IHCA).
  • To evaluate if extending epinephrine dosing intervals beyond current recommendations impacts survival outcomes in pediatric IHCA cases.

Main Methods:

  • A retrospective analysis was conducted using the AHA Get With The Guidelines-Resuscitation registry, including 1630 pediatric IHCAs.
  • Epinephrine dosing intervals were calculated by dividing the resuscitation duration by the number of doses administered, categorized into 1-5 min, >5 to <8 min, and 8 to <10 min per dose.
  • Multivariable logistic regression models were employed to control for various confounding factors, with a secondary analysis stratifying patients based on vasoactive infusion status at the time of arrest.

Main Results:

  • For the overall cohort, adjusted odds ratios for survival to hospital discharge were 1.81 (95% CI 1.26-2.59) for >5 to <8 min intervals and 2.64 (95% CI 1.53-4.55) for 8 to <10 min intervals, compared to the 1-5 min reference.
  • In patients not receiving vasoactive infusions, adjusted odds ratios for survival were 1.99 (95% CI 1.29-3.06) for >5 to <8 min intervals and 2.67 (95% CI 1.14-5.04) for 8 to <10 min intervals.
  • These results indicate a statistically significant association between longer epinephrine dosing intervals and improved survival rates.

Conclusions:

  • Longer average epinephrine dosing intervals during pediatric in-hospital cardiac arrest (IHCA) are associated with enhanced survival to hospital discharge.
  • The findings suggest a potential need to re-evaluate current epinephrine administration guidelines for pediatric IHCA.
  • Extended epinephrine dosing intervals may represent a viable strategy to improve outcomes in pediatric cardiac arrest resuscitation.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.1K
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
864
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
931
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.1K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
445
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
347